Sana Biotechnology Inc (SANA)
9.94
-0.06
(-0.60%)
USD |
NASDAQ |
May 07, 13:57
Sana Biotechnology Cash and Short Term Investments (Quarterly): 205.20M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 205.20M |
| September 30, 2023 | 268.57M |
| June 30, 2023 | 325.92M |
| March 31, 2023 | 349.31M |
| December 31, 2022 | 423.96M |
| September 30, 2022 | 485.75M |
| June 30, 2022 | 484.80M |
| March 31, 2022 | 512.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 551.00M |
| September 30, 2021 | 603.71M |
| June 30, 2021 | 852.84M |
| March 31, 2021 | 960.24M |
| December 31, 2020 | 378.26M |
| September 30, 2020 | 450.86M |
| December 31, 2019 | 138.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
138.98M
Minimum
Dec 2019
960.24M
Maximum
Mar 2021
466.12M
Average
450.86M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 373.18M |
| Solid Biosciences Inc | 123.64M |
| Dyne Therapeutics Inc | 453.55M |
| Taysha Gene Therapies Inc | 143.94M |
| Tenaya Therapeutics Inc | 104.64M |